相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lysophosphatidic Acid Induces alpha v beta 6 Integrin-Mediated TGF-beta Activation via the LPA2 Receptor and the Small G Protein G alpha(q)
Ming Yan Xu et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Contribution of Epithelial-derived Fibroblasts to Bleomycin-induced Lung Fibrosis
Harikrishna Tanjore et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells
Xin-Yan Zhao et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice
Xue-Mei Ou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Pirfenidone Is Renoprotective in Diabetic Kidney Disease
Satish P. RamachandraRao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Pulmonary fibrosis: pathogenesis, etiology and regulation
M. S. Wilson et al.
MUCOSAL IMMUNOLOGY (2009)
Prostaglandin F2α receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-β
Toru Oga et al.
NATURE MEDICINE (2009)
Effects of Pirfenidone on Proliferation, Migration, and Collagen Contraction of Human Tenon's Fibroblasts In Vitro
Xianchai Lin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
Hisashi Oku et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis
Annika Andersson-Sjoland et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
From lung injury to fibrosis
Klaus Ley et al.
NATURE MEDICINE (2008)
Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells
Eun Su Jeon et al.
STEM CELLS (2008)
MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis
Ivan O. Rosas et al.
PLOS MEDICINE (2008)
The lysophosphatidic acid receptor LPA(1) links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
Andrew M. Tager et al.
NATURE MEDICINE (2008)
LPA1 receptor activation promotes renal interstitial fibrosis
Jean-Philippe Pradere et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Molecular targets in pulmonary fibrosis - The myofibroblast in focus
Chris J. Scotton et al.
CHEST (2007)
Regulation of fibroblast functions by lysophospholipid mediators: Potential roles in wound healing
Kenneth R. Watterson et al.
WOUND REPAIR AND REGENERATION (2007)
Protective effect of orally administered carnosine on bleomycin-induced lung injury
Salvatore Cuzzocrea et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia
L. Tiitto et al.
THORAX (2006)
Incidence and prevalence of idiopathic pulmonary fibrosis
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases
Ahmed Boucharaba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells
B Saatian et al.
BIOCHEMICAL JOURNAL (2006)
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-ß1 -: Potential role in idiopathic pulmonary fibrosis
BC Willis et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase
JS Swaney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cell surface receptors in lysophospholipid signaling
B Anliker et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis
T Kakugawa et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Ki16425, a subtype-selective antagonist for EDG-Family lysophosphatidic acid receptors
H Ohta et al.
MOLECULAR PHARMACOLOGY (2003)
Time course of bleomycin-induced lung fibrosis
G Izbicki et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2002)
Myofibroblasts and mechano-regulation of connective tissue remodelling
JJ Tomasek et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Hepoxilin analogs inhibit bleomycin-induced pulmonary fibrosis in the mouse
RP Jankov et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
M Selman et al.
RESPIRATORY RESEARCH (2001)
Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals
HP Misra et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
分享论文
